Porreca, F; LoPresti, D; Ward, S J (1990) Opioid agonist affinity in the guinea-pig ileum and mouse vas deferens. Eur J Pharmacol 179:129-39
|
Tallarida, R J; Porreca, F; Cowan, A (1989) Statistical analysis of drug-drug and site-site interactions with isobolograms. Life Sci 45:947-61
|
Jiang, Q; Sheldon, R J; Porreca, F (1988) Sites of clonidine action to inhibit gut propulsion in mice: demonstration of a central component. Gastroenterology 95:1265-71
|
Heyman, J S; Williams, C L; Burks, T F et al. (1988) Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine. J Pharmacol Exp Ther 245:238-43
|
Sheldon, R J; Nunan, L; Porreca, F (1988) U50,488H differentially antagonizes the bladder effects of mu agonists at spinal sites. Eur J Pharmacol 146:229-35
|
Porreca, F; Nunan, L; Kazmierski, W et al. (1987) Effects of a novel opioid peptide antagonist on rat bladder motility in vivo. Peptides 8:625-32
|
Porreca, F; Heyman, J S; Mosberg, H I et al. (1987) Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse. J Pharmacol Exp Ther 241:393-400
|
Porreca, F; Tortella, F C (1987) Differential antagonism of mu agonists by U50,488H in the rat. Life Sci 41:2511-6
|
Jiang, Q; Sheldon, R J; Porreca, F (1987) A comparison of the central gastrointestinal antitransit effects of morphine and bombesin in the mouse. Life Sci 41:2455-61
|
Sheldon, R J; Nunan, L; Porreca, F (1987) Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo. J Pharmacol Exp Ther 243:234-40
|